Physician profile
John Saunders
NPI 1528653243
$1,008.54
in general payments reported to CMS, 2019-2025
15 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.16 · 2022: $158 · 2023: $215 · 2024: $434 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $274.26 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $170.25 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $88.28 | 2021-2023 | |
| Dexcom, INC. | $88.19 | 2023-2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $81.04 | 2021-2025 | |
| Currax Pharmaceuticals LLC | $51.14 | 2024 | Contrave |
| Amgen INC. | $49.28 | 2023-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.37 | 2025 | Jardiance, Ofev |
| Exact Sciences Corporation | $38.62 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.43 | 2023-2024 | Xifaxan, Trulance |
| Astrazeneca Pharmaceuticals Lp | $31.65 | 2022 | |
| Abbott Laboratories | $18.27 | 2025 | Freestyle Libre |
| Seqirus USA INC | $15.31 | 2022 | |
| Medtronic, INC. | $13.89 | 2024 | Minimed 780g |
| Idorsia Pharmaceuticals US INC | $13.56 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.